Clinical Trial News

Diversity in Clinical and Biomedical Research: A Promise Yet to Be Fulfilled

Diversity in Clinical and Biomedical Research: A Promise Yet to Be Fulfilled

PLoS Medicine, 15 December 2015 Summary Points Health disparities persist across race/ethnicity for the majority of Healthy People 2010 health indicators. Most physicians and scientists are informed by research extrapolated from a…

Who’s in Clinical Trials?

Who’s in Clinical Trials?

U.S. Food and Drug Administration, 9 December 2015 Have you ever wondered if someone like you participated in the clinical trials for a new drug? If you have, you’re not alone. That’s…

Addressing Health Disparities through Clinical Trials

Addressing Health Disparities through Clinical Trials

Media Planet: Future of Health Care, December 2015 Historically, participants in clinical trials have not proportionally represented the diversity of our population. This is a stat we can set about changing…

ABOUT THE CLINICAL TRIAL ENGAGEMENT NETWORK

The Clinical Trial Engagement Network will serve as the healthcare industry resource addressing a critical need in drug research – improving the representation of diverse populations, including African Americans, Asian Americans and Hispanics, in clinical trials. cten2 Clinical trial sponsors that join the Clinical Trial Engagement Network, gain exposure to, and connect with, clinical trial investigators and diverse patients who volunteer to be considered for clinical trials.  These sponsors can access the Clinical Trial Recruitment Center, a secure web-based tool containing zip code level maps showing not only these investigators and patient volunteers, but also disease prevalence and counts, clinical trial locations and minority-serving physicians, hospitals, clinics, academic research centers, physician networks and other points of care, patient advocacy organizations and key influencers serving diverse communities.

Statements

Comments by Dr. Gary A. Puckrein on the Food and Drug Administration’s FDASIA Section 907 Action Plan October 20, 2014

Comments by Dr. Gary A. Puckrein on the Food and Drug Administration’s FDASIA Section 907 Action Plan October 20, 2014

The National Minority Quality Forum (The Forum) commends the Food and Drug Administration upon the release…

What PhRMA's CEO is Saying

The Underlying Condition: Increasing Diversity in Clinical Trials

The Underlying Condition: Increasing Diversity in Clinical Trials

National Journal: February 20, 2014 John J. Castellani is president and CEO of the Pharmaceutical Research…

What the Industry is Saying

Pfizer supports development of the Clinical Trial Engagement Network

Pfizer supports development of the Clinical Trial Engagement Network

“Pfizer is working with the National Minority Quality Forum to push healthcare innovations to improve minority…

Clinical Trial News

Diversity in Clinical and Biomedical Research: A Promise Yet to Be Fulfilled

Diversity in Clinical and Biomedical Research: A Promise Yet to Be Fulfilled

PLoS Medicine, 15 December 2015 Summary Points Health disparities persist across race/ethnicity for the majority of Healthy People…

Other Forum Resources

Resources
 

 

National Minority Quality Forum
1101 K Street, NW
Suite 350
Washington, DC 20005

 

Tel: 202.223.7560
Fax: 202.223.7567
www.nmqf.org

Terms of Use     l    Privacy Policy